Fierce Healthcare March 16, 2023
Insurers are not doing enough to help providers participate in confirmatory trials of drugs that hit the market through accelerated approval, FDA Commissioner Robert Califf, M.D., said. (pcess609/iStock/Getty Images Plus)
WASHINGTON, D.C.—Insurers must do more to help providers participate in clinical trials that can confirm the effectiveness of drugs granted accelerated approval, Food and Drug Administration Commissioner Robert Califf, M.D., told a room full of payer executives Thursday.
Califf spoke about how to improve the accelerated approval process during a session at the AHIP 2023 Medicare, Medicaid, Duals & Commercial Markets Forum in Washington, D.C. The remarks come as the FDA has new powers granted by Congress to get drug companies to finish trials for drugs after they...
Today's Sponsors
Today's Sponsor
Topics: Biotechnology, Clinical Trials, FDA, Govt Agencies, Insurance, Pharma, Pharma / Biotech, Provider, Trends